May 25, 2021 / 04:00PM GMT
Navin Cyriac Jacob - UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic
Good afternoon, welcome to the UBS Global Healthcare Conference. My name is Navin Jacob, I cover smid-cap biotech and large-cap pharma here at UBS. I'm happy to have with me, for our next session, AbbVie Pharmaceuticals. And from AbbVie, we have Michael Severino, Vice Chairman and President; Rob Michael, SVP and CFO; Jeff Stewart, SVP and Head of Commercial Ops. Thank you, gentlemen, for joining me today. And we also have Liz Shea, Head of Investor Relations as well.
So we're -- this is going to be a Q&A fireside chat for the full 45 minutes. We do have an ability for our audience members to ask questions via this webcast, so if you do so, I will see those questions at the bottom of my screen. They are anonymous, so don't worry if you're shy and don't want to necessarily showcase who's coming -- who's asking the questions. Those are anonymous, and I will try and read those -- some of those questions out at the end of this session.
Thank you so
Abbvie Inc at UBS Global Healthcare Virtual Conference Transcript
May 25, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers